期刊文献+

第三代腺病毒载体的改良与应用 被引量:4

Modification and application of the third-generation adenovirus vectors
下载PDF
导出
摘要 腺病毒载体是一种非常有效的转基因载体,具有高效率、低致病性、高滴度及不整合入宿主细胞染色体等优点,广泛应用于基因治疗。第一、二代腺病毒载体仍有许多不足之处,在其基础上发展了第三代腺病毒载体。第三代腺病毒载体与前者相比,具有低免疫原性及高容量等优点,在基因治疗中表现出独特优势。然而,由于辅助病毒污染的存在及病毒产量有待提高,第三代腺病毒载体的临床应用仍面临一定困难。 Adenovirus as gene transfer vector is characterized by high transfection efficiency, high titer,good stability in target cells and low pathogenicity, and has been widely used in gene therapy. Compared to first- and second-generation adenovirus vectors, the third-generation adenovirus vectors have unique advantages for gene therapy because of their low immunogenicity and high capacity. However, the clinical application of the third-generation adenovirus vectors is hampered by the existance of helper contamination and difficulties in their large-scale production.
作者 陈琳 薛绪潮
出处 《第二军医大学学报》 CAS CSCD 北大核心 2007年第7期722-725,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30571830).~~
关键词 第三代腺病毒 遗传载体 辅助病毒 third-generation adenovirus genetic vectors helper viruses
  • 相关文献

参考文献1

二级参考文献46

  • 1Abruzzese RV, Godin D, Mehta V, et al. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible Gene Switch system. Mol Ther 2000: 2:276-87.
  • 2Prieto J, Qian C, Sangro B, Melero Ⅰ, Mazzolini G. Biological therapy of liver tumors. Surg Clin North Am 2004; 84:643-57.
  • 3Trinchieri G. Interleukin- 12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83-243.
  • 4Caruso M, Pham-Nguyen K, Kwong YL, et al, Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.Proc Natl Acad Sci U S A 1996: 93:11302-6.
  • 5Mazzolini G, Qian C, Xie X, et al. Tumor regression and long-term protection for colon cancer after intratumoral injection of adenovirus expressing IL-12. Cancer Gene Ther 1999; 5:514-22.
  • 6Barajas M, Mazzolini G, Genove G, et al, Gene Therapy of Orthotopic Hepatocellular Carcinoma in Rats Using Adenovirus Coding for interleukin-12 (IL-12). Hepatology 2001; 33:52-61.
  • 7Liu Y, Ehtesham M, Samoto K, et al. In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 2002: 9:9-15.
  • 8Nasu Y, Bangma CH, Hull GW, et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model Gene Ther 1999: 6:338-49.
  • 9Zhang R, DeGroot LJ. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin- 12. Endocrinology 2003; 144:1393-8.
  • 10Wang L, Hemandez-Aicoceba R, Shankar V, et al. Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy tbr liver cancer. Gastroenterology 2004; 126: 278-89.

共引文献12

同被引文献81

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部